Sign in
GTH Stock Price, Chart, Stats & News
Genetron Holdings Limited
Save
127.29M
Market cap
–
Current P/E
–
Forward P/E
GTH chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 43.25% |
Operating margin | -97.07% |
Pretax margin | -124.58% |
Net margin | -135.84% |
Effective tax rate | -9.04% |
ROA | -90.62% |
ROE | -100.92% |
D/E | 0.29x |
Interest coverage ratio | -5.67x |
GTH valuation
P/E | – |
P/S | 1.35x |
P/B | 1.58x |
P/CF | -1.87x |
P/FCF | -1.62x |
P/OCF | -1.87x |
PEG | -0.00x |
EV multiple | -1.38x |
About
Genetron Holdings Limited (GTH) is a precision oncology company that specializes in cancer molecular profiling, utilizing advanced molecular biology and data science to enhance cancer treatment. The company delivers a range of services, including diagnosis, monitoring, and early screening, primarily through its proprietary laboratory-developed tests. Its product offerings encompass a variety of in-vitro diagnostic (IVD) solutions.
Similar securities
Based on sector and market capitalization
Report issue